GLTO
Price
$27.84
Change
+$4.24 (+17.97%)
Updated
Nov 13 closing price
Capitalization
36.95M
Intraday BUY SELL Signals
TELO
Price
$1.30
Change
-$0.05 (-3.70%)
Updated
Nov 13 closing price
Capitalization
44.15M
19 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GLTO vs TELO

Header iconGLTO vs TELO Comparison
Open Charts GLTO vs TELOBanner chart's image
Galecto
Price$27.84
Change+$4.24 (+17.97%)
Volume$2M
Capitalization36.95M
Telomir Pharmaceuticals
Price$1.30
Change-$0.05 (-3.70%)
Volume$307.9K
Capitalization44.15M
GLTO vs TELO Comparison Chart in %
GLTO
Daily Signal:
Gain/Loss:
TELO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GLTO vs. TELO commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLTO is a Buy and TELO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (GLTO: $23.60 vs. TELO: $1.35)
Brand notoriety: GLTO and TELO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLTO: 98% vs. TELO: 79%
Market capitalization -- GLTO: $36.95M vs. TELO: $44.15M
GLTO [@Biotechnology] is valued at $36.95M. TELO’s [@Biotechnology] market capitalization is $44.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLTO’s FA Score shows that 0 FA rating(s) are green whileTELO’s FA Score has 0 green FA rating(s).

  • GLTO’s FA Score: 0 green, 5 red.
  • TELO’s FA Score: 0 green, 5 red.
According to our system of comparison, GLTO is a better buy in the long-term than TELO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLTO’s TA Score shows that 7 TA indicator(s) are bullish while TELO’s TA Score has 2 bullish TA indicator(s).

  • GLTO’s TA Score: 7 bullish, 3 bearish.
  • TELO’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, GLTO is a better buy in the short-term than TELO.

Price Growth

GLTO (@Biotechnology) experienced а +297.31% price change this week, while TELO (@Biotechnology) price change was -2.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

TELO is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TELO($44.1M) has a higher market cap than GLTO($36.9M). GLTO YTD gains are higher at: 407.527 vs. TELO (-67.233). TELO has higher annual earnings (EBITDA): -16.08M vs. GLTO (-16.94M). GLTO has more cash in the bank: 10.2M vs. TELO (754K). GLTO (0) and TELO (0) have equivalent revenues.
GLTOTELOGLTO / TELO
Capitalization36.9M44.1M84%
EBITDA-16.94M-16.08M105%
Gain YTD407.527-67.233-606%
P/E RatioN/AN/A-
Revenue00-
Total Cash10.2M754K1,353%
Total Debt75KN/A-
TECHNICAL ANALYSIS
Technical Analysis
GLTOTELO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
GLTO
Daily Signal:
Gain/Loss:
TELO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRRFY11.85N/A
N/A
Premier Foods Plc.
POLE10.57-0.01
-0.09%
Andretti Acquisition Corp. II
BZLFY14.68-0.10
-0.68%
Bunzl plc
CLIR0.83-0.03
-3.27%
ClearSign Technologies Corp
SNDX16.79-0.94
-5.30%
Syndax Pharmaceuticals

GLTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLTO has been loosely correlated with VIVS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if GLTO jumps, then VIVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLTO
1D Price
Change %
GLTO100%
+0.08%
VIVS - GLTO
38%
Loosely correlated
-2.16%
KZR - GLTO
34%
Loosely correlated
-0.32%
SYRE - GLTO
34%
Loosely correlated
+0.34%
KPTI - GLTO
33%
Poorly correlated
+2.38%
CMMB - GLTO
32%
Poorly correlated
+0.37%
More

TELO and

Correlation & Price change

A.I.dvisor tells us that TELO and CRSP have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TELO and CRSP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TELO
1D Price
Change %
TELO100%
-4.93%
CRSP - TELO
32%
Poorly correlated
-5.47%
ABCL - TELO
31%
Poorly correlated
-1.00%
ENGN - TELO
29%
Poorly correlated
-1.59%
GLTO - TELO
28%
Poorly correlated
+0.08%
LITS - TELO
28%
Poorly correlated
-3.37%
More